SQZ Biotechnologies

formerly SQZ BiotechClosed

SQZ Biotechnologies is a biotech company in Watertown, United States, founded in 2013. It has raised $166.0M across 4 rounds, most recently a $65.0M Series D in May 2020.

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$166.0M
Last Round
$65.0M Series DMay 2020
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.

About

SQZ Biotechnologies was a Watertown, Massachusetts-based clinical-stage biotechnology company spun out of MIT that developed Cell Squeeze, a microfluidic cell-engineering platform used to create cell therapies for cancer and other diseases. After halting its lead antigen-presenting cell therapy program in 2023, SQZ's shareholders approved a plan in February 2024 to sell substantially all of its assets to STEMCELL Technologies for roughly $11.8 million and dissolve the company, a process completed in March 2024.

Summary

It lists 51–200 employees. It has raised $166.0M in total across 4 rounds, most recently a $65.0M Series D round in May 2020. Investors include Polaris Partners, Temasek and GV.

Funding History

Data from Indexed.vcUpdated
Series DSeries DMay 2020
$65.0M

Sign up to see all 4 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SQZ Biotechnologies on Indexed.vc
<a href="https://indexed.vc/companies/sqz-biotechnologies"><img src="https://indexed.vc/api/badge/company/sqz-biotechnologies" alt="SQZ Biotechnologies on Indexed.vc" width="260" height="76" /></a>